Post-Acute Withdrawal Syndrome (PAWS) and HBOT: Why Medical Recovery Matters

Clinically reviewed by Dr. Aviva Wolf — Consultant Psychiatrist · Last reviewed 7 July 2026

Recovery from addiction rarely follows a straight line. For many people, the early days of sobriety bring a sense of relief — only to be followed weeks or even months later by a wave of exhaustion, emotional volatility, cognitive fog, and an almost inexplicable craving that seems to arrive from nowhere. This experience has a name: Post-Acute Withdrawal Syndrome (PAWS), and it is more common, and more medically significant, than most people are ever told.

PAWS occurs because addiction reshapes the brain at a neurological level. When the substance is removed, the brain does not simply bounce back overnight. Instead, it undergoes a prolonged process of rebalancing neurotransmitter systems, restoring cellular function, and rebuilding the neural pathways that chronic substance use has altered. This process can unfold over months, and without proper medical support, it can become a significant driver of relapse — not because someone lacks willpower, but because their brain is still healing.

This is precisely why the conversation around HBOT PAWS treatment is gaining serious momentum within evidence-based rehabilitation medicine. Hyperbaric Oxygen Therapy, or HBOT, offers a physician-supervised approach to supporting the brain’s recovery during this vulnerable window. At Holina Rehab in Koh Phangan, Thailand, HBOT is integrated into personalised treatment programmes designed to address the complex biological realities of prolonged withdrawal — not as an isolated intervention, but as part of a genuinely holistic medical recovery journey.

Understanding why medical recovery matters begins with understanding what your brain is actually going through.

What Is Post-Acute Withdrawal Syndrome — and Why Does It Last So Long?

Most people entering residential treatment understand that the first days and weeks of stopping alcohol or drugs will be physically difficult. What far fewer people are prepared for is what comes next. Post-Acute Withdrawal Syndrome, commonly referred to as PAWS, is a prolonged neurological and physiological recovery process. The American Society of Addiction Medicine describes it as subacute symptoms — irritability, anxiety, and sleep disturbance — that persist beyond 30 days from the start of acute withdrawal, and a systematic review of the post-acute alcohol withdrawal literature found these symptoms are typically most pronounced in the first four to six months of abstinence, with some — particularly sleep disruption and cognitive effects — gradually easing over a longer period. It is one of the most under-discussed — and underestimated — obstacles to sustained recovery.

PAWS arises because addiction fundamentally rewires the brain. Prolonged substance use disrupts the balance of key neurotransmitter systems, particularly dopamine, serotonin, GABA, and glutamate. When the substance is removed, the brain does not simply snap back to its pre-addiction state. Instead, it enters a slow, uneven process of neurobiological recalibration. During this period, the prefrontal cortex — responsible for decision-making, impulse control, and emotional regulation — continues to function below its optimal capacity. This is not a character flaw or lack of willpower. It is measurable neurological disruption with real clinical consequences.

The symptoms of PAWS vary between individuals and across different substances, but commonly include:

• Persistent low mood, emotional flatness, or waves of anxiety that appear without obvious trigger
• Cognitive difficulties including poor concentration, memory lapses, and mental fog
• Disrupted sleep architecture, including difficulty falling asleep, staying asleep, or feeling rested
• Heightened sensitivity to stress, with disproportionate emotional responses to everyday situations
• Anhedonia — a reduced or absent ability to feel pleasure from activities that were once enjoyable
• Fatigue and low physical energy that does not resolve with rest
• Cravings that seem to arrive unpredictably, often triggered by stress or exhaustion

These symptoms are cyclical in nature. They may ease for a period, then resurface — often triggered by physical illness, emotional stress, or disrupted sleep. This unpredictability is itself one of the most distressing aspects of PAWS, leaving many people in early recovery feeling destabilised and uncertain about whether they are making genuine progress.

Understanding PAWS as a legitimate medical condition — rather than a psychological weakness — changes the entire framework of how recovery should be approached. It makes clear why physician-supervised, residential care that extends well beyond the initial acute phase — delivered within a licensed clinical setting (see our clinical licensing) — is not a luxury but a clinical necessity. It also opens the door to exploring evidence-based medical interventions that directly support the brain’s recovery process, including targeted therapies that address oxygen metabolism, inflammation, and neurological repair at a physiological level.

How Hyperbaric Oxygen Therapy Supports the Healing Brain During PAWS

One of the most significant challenges in long-term recovery is that the brain — after months or years of substance dependence — is genuinely injured. Chronic alcohol and drug use disrupts cerebral blood flow, depletes neurotransmitter reserves, damages myelin sheaths, and creates regions of low metabolic activity that persist long after the last drink or dose. Post-Acute Withdrawal Syndrome is, in many ways, a neurological condition as much as a psychological one. This is precisely why evidence-based medical interventions, rather than willpower alone, make such a profound difference in sustained recovery outcomes.

Hyperbaric Oxygen Therapy (HBOT) works by delivering pure oxygen at pressures greater than normal atmospheric levels inside a pressurised chamber. Under these conditions, oxygen dissolves directly into the plasma, cerebrospinal fluid, and tissues — reaching areas where compromised circulation has left cells starved of the fuel they need to repair and function. For individuals navigating the prolonged neurological disruption of PAWS, this mechanism is clinically relevant in several specific ways.

Research into HBOT’s neuromodulatory effects has identified a number of physiologically important outcomes relevant to the recovering brain:

• Improved cerebral blood flow: HBOT promotes angiogenesis — the formation of new blood vessels — and is associated with reduced neuroinflammation, supporting circulation to brain regions that have been chronically underperfused due to substance-related damage.
• Reduced oxidative stress: Substance dependence generates significant oxidative damage at a cellular level. Controlled hyperoxia from HBOT has been shown to upregulate the body’s own antioxidant systems, potentially reducing the inflammatory burden on neural tissue.
• Support for neuroplasticity: Elevated tissue oxygen levels are linked to increased production of brain-derived neurotrophic factor (BDNF), a protein involved in forming new neural connections — relevant to the cognitive repair that PAWS so persistently disrupts.
• Mitochondrial support: Oxygen is the essential substrate for mitochondrial energy production. Restoring adequate oxygenation to struggling cells can help normalise energy metabolism, which is relevant to the fatigue, cognitive fog, and mood instability characteristic of PAWS.
• Reduced neuroinflammation: Chronic substance use activates microglial cells, producing a sustained inflammatory state in the brain. HBOT has demonstrated measurable anti-inflammatory effects (including reduced TNF-α and IL-6) in the broader neuromodulation literature.

This is not only theoretical. A randomised controlled trial of adults tapering off methadone for opioid use disorder found that five sessions of hyperbaric oxygen therapy reduced opioid withdrawal symptom severity by roughly half, on average, compared with standard care, and participants described the sessions as feasible and well-tolerated. The trial was small (31 participants) and its authors describe it as an early feasibility study rather than definitive proof of efficacy — but it is a genuine, peer-reviewed signal that HBOT can meaningfully ease withdrawal-related symptoms under medical supervision, in exactly the population PAWS affects.

At Holina Rehab, HBOT is never offered as a standalone solution. It is integrated within a physician-supervised, personalised treatment framework that includes psychiatric care from our clinical team, evidence-based therapies such as CBT and EMDR, nutritional medicine, and mindfulness-based approaches. Sessions are conducted under close medical oversight, with each client’s response carefully monitored and their programme adjusted accordingly. This level of clinical attentiveness — within a residential setting that genuinely prioritises comfort and dignity — reflects a fundamental conviction: that the body and brain deserve the same quality of care as the mind during recovery.

Understanding that PAWS has a biological substrate, and that this substrate can be meaningfully supported through targeted medical therapies, shifts recovery from something that simply happens to a person into something they can actively and intelligently pursue — with the right clinical team beside them.

How Holina Rehab Integrates HBOT Into a Medically Supervised PAWS Recovery Plan

Managing Post-Acute Withdrawal Syndrome effectively requires far more than willpower or time alone. At Holina Rehab on Koh Phangan, Thailand, HBOT is never offered as a standalone treatment — it is woven into a carefully structured, physician-supervised programme that addresses the neurological, physiological, and psychological dimensions of prolonged withdrawal simultaneously. This integrated approach is what separates genuine medical recovery from surface-level symptom management.

From the moment a resident arrives, our medical team conducts a comprehensive clinical assessment to identify the specific PAWS profile they are presenting with. Because PAWS manifests differently depending on the substance involved, the duration of use, and the individual’s neurological baseline, no two treatment plans are identical. Alcohol-related PAWS, for example, tends to involve pronounced anxiety, sleep disruption, and emotional dysregulation, while opioid-related PAWS commonly presents with prolonged anhedonia, fatigue, and cognitive fog. HBOT sessions are scheduled and dosed in response to these individual presentations, rather than applied as a generic protocol.

A typical HBOT-inclusive treatment week at Holina may include:

• Physician-led medical reviews to monitor neurological symptoms, adjust session frequency, and track measurable progress in sleep quality, cognitive function, and mood stability
• HBOT sessions in a pressurised hyperbaric chamber, during which residents breathe pure oxygen at increased atmospheric pressure, supporting cerebral blood flow and neurological repair
• Evidence-based psychotherapy, including Cognitive Behavioural Therapy and trauma-informed modalities, to address the emotional volatility and craving cycles that PAWS perpetuates
• Nutritional medicine support, recognising that prolonged substance use depletes critical micronutrients — including B vitamins, magnesium, and zinc — that are important for neurotransmitter synthesis and brain recovery
• Mindfulness-based stress reduction practices, which have demonstrated clinical benefit in reducing hyperarousal and emotional dysregulation in early recovery
• Restorative physical movement, including yoga and guided exercise, which supports dopaminergic recovery and improves the sleep architecture that PAWS so frequently disrupts

This level of individualised, physician-led care is reflected in Holina’s published programme pricing, which covers medical oversight, HBOT sessions, and residential care as a single package rather than itemised extras.

Residents recovering within Holina’s residential environment benefit from the additional therapeutic value of a calm, structured setting — something that is clinically relevant rather than simply a comfort consideration. Chronic stress can impair neurological repair, and the serene natural surroundings of Koh Phangan, combined with consistent daily rhythms, are intended to support the conditions in which the brain can heal.

PAWS is not a personal failing, and it is not something a person simply has to endure in silence. With the right medical framework — one that combines emerging interventions like HBOT with robust psychological care, nutritional support, and personalised oversight — the timeline and intensity of post-acute withdrawal can be meaningfully supported. If you or someone you care about is struggling with the prolonged effects of withdrawal and finding that early recovery feels harder than expected, reaching out to a qualified medical team is not a sign of weakness. It is a clinically sound decision.

Recovery from addiction is rarely a straight line, and Post-Acute Withdrawal Syndrome is one of the most significant — and most frequently overlooked — reasons why. The mood swings, cognitive fog, disrupted sleep, and emotional volatility that characterise PAWS are not signs of weakness or poor motivation. They are measurable neurological events, rooted in genuine physiological changes that take time, support, and targeted clinical intervention to resolve. Understanding this distinction is not simply academic; it is the foundation upon which lasting, meaningful recovery is built.

Hyperbaric Oxygen Therapy represents one of the more compelling emerging tools in the treatment of PAWS, offering a non-invasive, physician-supervised pathway that current research links to accelerated neural repair, reduced neuroinflammation, and improved cognitive restoration. When integrated thoughtfully within a broader, personalised treatment programme — one that combines psychiatric care, evidence-based trauma therapy, nutritional medicine, and restorative wellness — HBOT becomes a meaningful component of a genuinely comprehensive healing journey, rather than an isolated intervention.

At Holina Rehab, nestled in the serene surroundings of Koh Phangan, Thailand, our multidisciplinary medical team designs every treatment plan around your unique neurological and psychological profile. If you or someone you love is navigating the complexities of prolonged withdrawal, we invite you to reach out and speak confidentially with our clinical team today.